Shield

DIGITAL ALLY, INC ANNOUNCES THIRD QUARTER 2023 OPERATING RESULTS

Retrieved on: 
Wednesday, November 15, 2023
Sale, Acquisition, Senior, Business analyst, Loan agreement, Revenue cycle management, Practice management, Marketing, Assignment, Closing, Tripura Merger Agreement, George M. Steinbrenner Field, Health care, Brickell Avenue, Growth, Plan, 2019 Digital Ally 400, News, EDT, Revolving Loan Fund, Entertainment, Suite, Form, Traction, DGLY, Security agreement, Total, ID, Sub, File, Prospectus, Security, Record, Mortgage loan, Prime rate, Debtor, Social media, Kompass Karten, Reserve (accounting), Loan, Cryptocurrency, Music, Pharmaceutical industry, Holding company, Credit, Security (finance), Life insurance, Kustom, Mergers and acquisitions, Shield

LENEXA, Kansas, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company” or “our”), today announced its operating results for the third quarter 2023.

Key Points: 
  • LENEXA, Kansas, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company” or “our”), today announced its operating results for the third quarter 2023.
  • An investor conference call is scheduled for 11:15 a.m. EDT on Wednesday, November 15, 2023 (see details below).
  • We reported an operating loss of $5,148,043 and $6,567,023 for the three months ended September 30, 2023 and 2022, respectively, an improvement of $1,418,980 (22%).
  • The Company will host an investor conference call at 11:15 a.m. EDT on Wednesday, November 15, 2023, to discuss its third quarter 2023 financial results, corporate and individual subsidiary outlook, and previously announced corporate separation.

Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results

Retrieved on: 
Monday, November 13, 2023
Durvalumab, Neck, Research, NYSE, Shield, GMP, Safety, Telephone, Head, Conference call, Clinical trial, ESMO, HCT, Patient, FDA, Cancer, VCN, Therapy, Conference, University, SITC, Survival, Congress, CPS, KOL, ICO, Travel, University of Pennsylvania, Pharmaceutical industry, Cryptocurrency, PDAC

ET -

Key Points: 
  • ET -
    ROCKVILLE, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.
  • Third Quarter Ended September 30, 2023 Financial Results
    General and administrative expenses decreased to $212,000 for the three months ended September 30, 2023, from $2.4 million for the three months ended September 30, 2022.
  • Theriva Biologics will host a conference call on Monday, November 13, 2023, at 8:30 a.m.
  • ET to discuss its financial results for the quarter ended September 30, 2023 and provide a corporate update.

Midwest Trading Group Expands Portfolio with Strategic Acquisition of TYLT

Retrieved on: 
Thursday, December 14, 2023
Hardware, Consumer Electronics, Mobile, Wireless, Other Technology, Technology, Electronics, DRW Trading Group, Acquisition, MTG, Creativity, Folio, Crest, Shield

Midwest Trading Group (MTG), a leading player in the consumer electronics sector, proudly announces the successful acquisition of TYLT, a renowned consumer electronics company known for its innovative and cutting-edge mobile phone accessories.

Key Points: 
  • Midwest Trading Group (MTG), a leading player in the consumer electronics sector, proudly announces the successful acquisition of TYLT, a renowned consumer electronics company known for its innovative and cutting-edge mobile phone accessories.
  • This strategic move is set to fortify MTG's position in the market and enhance its ability to provide top-notch solutions to customers worldwide.
  • The acquisition of TYLT brings together two industry leaders, combining their expertise and resources to create a powerhouse of innovation.
  • This acquisition marks a significant step forward in MTG's commitment to delivering unparalleled value to old and new customers.

Shields Health Solutions Awards Two Resident Research Grants to Advance Health System Specialty Pharmacy

Retrieved on: 
Tuesday, December 5, 2023
Research, Medical Supplies, Health Technology, Health, University, Pharmaceutical, General Health, Science, Education, Disease, DRS, MTM, Patient satisfaction, Medication therapy management, Doctor of Pharmacy, Pharmacist, Medication, Mortality, Patient, Shield, Workflow, Observational study, UC, Nursing, Hospital, Pharmacy

Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, is proud to award resident research grants in the amount of $5,000 to supplement two existing initiatives advancing health system specialty pharmacy in 2024.

Key Points: 
  • Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, is proud to award resident research grants in the amount of $5,000 to supplement two existing initiatives advancing health system specialty pharmacy in 2024.
  • This marks the fourth consecutive year Shields has offered grants to qualified health systems in the interest of furthering health system-based specialty pharmacy.
  • “By enhancing specialty pharmacy services, we can help health systems deliver high quality and cost-efficient care for complex patients,” said Brian Smith, Chief Pharmacy Officer at Shields.
  • Jennifer Chang, PharmD and Tiffany Tsai, PharmD of UC Davis Health earned the research grant for their project titled Impact of Integrated Clinical Pharmacy Services on Patient Outcomes in a Cardiac Rehabilitation Program.

MLS Team Sponsorship Revenue Nears $600 Million

Retrieved on: 
Thursday, December 7, 2023
Inter Miami CF, Shield, Body armor, LA Galaxy, Football, Insurance, NFT, Intelligence, Marketing, MLS, Adidas, Health, Houston Dynamo FC, Lead, Partnership, FC Cincinnati, Apple, Growth, Sporting Kansas City, Sport, Supporter, Pharmaceutical industry

STAMFORD, Conn., Dec. 7, 2023 /PRNewswire/ -- SponsorUnited, the leading global sports and entertainment intelligence platform tracking over 1.6 million sponsorships and endorsements for 330,000 brands, today released its annual 2023 MLS Marketing Partnerships Report highlighting continued growth, top trends and new sponsorship formats for the league in 2023.

Key Points: 
  • MLS team sponsorship revenue nears $600 Million in latest marketing partnerships report from SponsorUnited.
  • The average number of sponsorships per team rose from 65 to 75, with over half of the teams registering double-digit increases in deals.
  • "The surge in MLS's team sponsorship revenue to over half a billion dollars is a remarkable testament to the league's rising prominence and their ability to leverage the global excitement of the World Cup, Messi's star power and the Apple partnership," said Bob Lynch, Founder and CEO of SponsorUnited.
  • MLS team sponsorship revenue soared to a record $587 million, a 15% year-over-year increase.

2023 MEI Awards Final Evaluation Successfully Held

Retrieved on: 
Thursday, November 30, 2023
Carbon, MEI, Eco-friendly dentistry, Construction, Copper, Gold, Student, Commerce, Gold Awards, University, Tsinghua University, Aircraft, Communication, Government, Silver, Gold Award, Management, Shield

NANJING, China, Nov. 30, 2023 /PRNewswire/ -- The recently concluded 2023 MEI Awards Final Evaluation in Nanjing unveiled a range of remarkable innovations.

Key Points: 
  • NANJING, China, Nov. 30, 2023 /PRNewswire/ -- The recently concluded 2023 MEI Awards Final Evaluation in Nanjing unveiled a range of remarkable innovations.
  • After multiple rounds of rigorous evaluations by the jury, 12 Gold Awards, 24 Silver Awards, 3 Best Innovation Concept Awards, along with several Selected Awards and Enterprise Awards were finally revealed.
  • Out of the vast pool of entries, a total of 617 products were selected to the final evaluation.
  • Mr. Ben Z. Orenstein, representing international buyers, joined the final evaluation jury for the first time.

LENNAR ANNOUNCES FIRST RELEASE OF THREE NEW AFFORDABLE, SINGLE-FAMILY HOME PLANS AT THREE LOCATIONS ACROSS CALIFORNIA'S CENTRAL VALLEY

Retrieved on: 
Tuesday, November 28, 2023
Sale, Lennar, Temperance, Shield, Heart, Clovis Unified School District, School, Life, Tourism, Central California

With pricing starting in the mid $300,000s, these new plans, located in Shafter, Fresno and Clovis, will be released for sale on Tuesday, November 28.

Key Points: 
  • With pricing starting in the mid $300,000s, these new plans, located in Shafter, Fresno and Clovis, will be released for sale on Tuesday, November 28.
  • Home shoppers are invited to tour these new plans virtually on Lennar.com.
  • "We are delighted to bring affordable single-family homes that will fill the need for a lower priced, quality home in the market," said Mike Miller, Lennar Central Valley Division President.
  • "This series of homes offers a great value in desirable locations that will appeal to Central California home shoppers."

Fur La La La La: Suavitel® Introduces Limited-Edition Cuddle Crewneck Sweater for Pets & Their Parents to Cozy Up Together This Holiday Season

Retrieved on: 
Thursday, November 16, 2023
Pet, Family Dollar, Parent, Shield, Walmart, MSRP

NEW YORK, Nov. 16, 2023 /PRNewswire/ -- Get ready to hug your pets like never before! Suavitel®, a leading fabric conditioner brand, is bringing fur families even closer together with the limited-edition Suavitel® Cuddle Crewneck. This one-of-a-kind sweater is designed for pet parents and their furry best friend to wear together for a heartwarming, picture-purrfect cuddle moment. Yes, that's right -- a sweater that has head holes for both people and their pets. 

Key Points: 
  • Suavitel®, a leading fabric conditioner brand, is bringing fur families even closer together with the limited-edition Suavitel® Cuddle Crewneck.
  • This one-of-a-kind sweater is designed for pet parents and their furry best friend to wear together for a heartwarming, picture-purrfect cuddle moment.
  • In celebration of the new innovation, Suavitel® Shed Shield , the brand has created the ultimate cozy cuddle fashion statement—the Suavitel® Cuddle Crewneck.
  • Pet parents can get their paws on one of two styles: a two-person + one pet sweater design – or – a one-person + one pet sweater design.

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

Retrieved on: 
Monday, November 13, 2023
Shield, DNA, Colorectal cancer, Neoplasm, CRC, Disease, Mortality, Colonoscopy, Patient, Large intestine, Fear, ECLIPSE, Helmy Eltoukhy, Cancer, Samsung Medical Center, Medical imaging

SINGAPORE, Nov. 12, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.

Key Points: 
  • SINGAPORE, Nov. 12, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
  • "The Shield blood test can broaden the range of choices for colorectal cancer screening.
  • "We are pleased to be able to help address the high rates of colorectal cancer in South Korea by introducing the Shield test at Samsung Medical Center," said Simranjit Singh, Chief Executive Officer of Guardant Health Asia, Middle East & Africa.
  • "We are confident that this revolutionary screening test will help healthcare professionals detect colorectal cancer early, when it's most treatable, with a simple blood draw."

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

Retrieved on: 
Monday, November 13, 2023
Shield, DNA, Colorectal cancer, Neoplasm, CRC, Disease, Mortality, Colonoscopy, Patient, Large intestine, Fear, ECLIPSE, Helmy Eltoukhy, Cancer, Samsung Medical Center, Medical imaging

SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.

Key Points: 
  • SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
  • "The Shield blood test can broaden the range of choices for colorectal cancer screening.
  • "We are pleased to be able to help address the high rates of colorectal cancer in South Korea by introducing the Shield test at Samsung Medical Center," said Simranjit Singh, Chief Executive Officer of Guardant Health Asia, Middle East & Africa.
  • "We are confident that this revolutionary screening test will help healthcare professionals detect colorectal cancer early, when it's most treatable, with a simple blood draw."